Medical Marijuana, Inc.  (MJNA)

Obviously, when you purchase marijuana on the street, you’re not always sure what you’re getting. With different potencies and strains and even the fact that people lace weed with other drugs on occasion, buying marijuana from a dealer is a gamble. Not to mention, purchasing it on the streets is illegal. However, now that medical marijuana is becoming more well known and accepted throughout the country, many are lobbying for safe access to medicinal marijuana to alleviate any issues associated with purchasing marijuana and the regulation of it.

Medical Marijuana, Inc. (OTC: MJNA) are among those who are fighting for the cause. They were the ones to pave the way in the United States as the first publicly traded cannabis company. From April 7th to the 11th, representatives from MJNA attended the 5th Annual National Medical Cannabis Unity Conference at Omni Shoreham Hotel in Washington, DC. Experts, including scientists, gathered at this location to discuss the latest research regarding medical cannabis.

At the conference, MJNA, among other major players in the medicinal cannabis industry, centered the conference around devising common-sense policies and safety regulations in relation to access and the usage of medicinal marijuana. Chief Executive Officer, Dr. Stuart Titus, of MJNA participated on the “Exciting Developments in Cannabis Research & Access” panel on April 8th. During this meeting, Dr. Titus was one of the experts on the panel who brought the recent breakthroughs in medical cannabis research to the attention of the group. On the following day, another leading name in the marijuana industry, Dion Markgraaff, participated in the “Global Medical Cannabis Policy & Lessons Learned” panel. On this particular panel, Markgraaff and the other participates discussed the latest efforts taken around the world to provide people with more access to medical cannabis. Part of the discussion focused on Mexico’s changing policy on cannabis for medical issues. MJNA’s product, THC-free Real Scientific Hemp Oil-X™ (RSHO-X™), became the first cannabis-related product to gain approval from Mexico’s government for importation. On April 10th, the CEO of MJNA’s public relations department, Andrew Hard, attended the “CBD-Only States” workshop.

All participants in the events over the course of the five days played an important role in history. They are altering the course of the future for those who could benefit from the usage of marijuana as a medical treatment. During the conferences, all of those who spoke in front of representatives had an opportunity to persuade officials to change their attitude regarding the substance.

A poll conducted back in 2013 showed that Republicans didn’t agree with the legalization of marijuana. In fact, the results concluded 65 percent of Democrats supported marijuana legalization and so did 62 percent of independents. On the contrary, only 35 percent of Republicans agreed with legalizing it, which may mean Medical Marijuana Inc. and other similar groups may still have some convincing to do.

The results of the conference aren’t totally certain as to whether the president and his cabinet are swayed to take a less conservative view on the subject. Many Americans are hoping they lighten their views on the usage of marijuana for recreational and medical purposes. At this point, the government officials can establish and protect safe and legal access for many Americans by acting quickly.

Even prior to the conference, the use of recreational marijuana has been increasing in the country, as noted by the Substance Abuse and Mental Health Administration (SAMHA). Results of a nationwide survey conducted in 2012 denoted 7.3 percent of Americans 12 or older used marijuana regularly in 2010, which is an increase from 2005 when a study indicated 5.8 percent of Americans 12 or older regularly used marijuana recreationally. The use of medical marijuana has been on the rise. This is especially the case since 44 states have, the District of Columbia and two U.S. territories, Guam and Puerto Rico, have given residents the privilege to cultivate, possess and obtain cannabis and cannabis products under the direction of a doctor with a specialized license.

Polls conducted throughout the years indicate more and more Americans support the legalization of marijuana for medicinal and recreational purposes as well. Results of one poll published by CBS News revealed that 67 percent of adults ages 18 to 29 supported the legalization of marijuana, which is higher than any other age group. A high percentage of seniors supported marijuana legalization, 45 percent to be exact. The National Public Radio (NPR) published a poll stating that 78 percent of Americans believe in legalizing marijuana for medicinal reasons.

Ultimately, if legislation is changed, this means more than just changes for patients who require medicinal marijuana to reduce pain and nausea. It also has an impact on how government officials view the use of marijuana in general. The conference was an opportunity to persuade these representatives to support the usage of the cannabis for medical purposes, especially since new implications will make the use of it more heavily regulated. There will in return be less “gray” area since regulations will be static among the medicinal marijuana community.

About the Author

Stuart Smith is the CEO and Founder of is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit